US Preventive Inhaler Market Size, Share, Analysis, Industry Report and Forecast 2019-2025

US preventive inhaler market is anticipated to grow at a substantial rate of 1.2% during the forecast period. The growth of the market of preventive inhalers in the US is mainly driven by factors that include the growing prevalence of chronic diseases such as asthma, diabetes, respiratory lung diseases and so on. Asthma is chronic inflammation of the lung airways that causes breathlessness and coughing. The number of people with asthma grows every year in the US. According to CDC, there are around 26 million asthma patients in the US, among which, nearly 18.9 million are adults and 7.1 million are children. Moreover, the prevalence of asthma in children is nearly 9.4% which is higher than that of adults accounting to around 7.7%, and higher in females nearly 9.2% than in males accounting to 7% of total asthma patients. This is one of the primary reasons for the high growth rate of the market within the country.

To Request a Sample of our Report on US Preventive Inhaler Market:  https://www.omrglobal.com/request-sample/us-preventive-inhaler-market

The US preventive inhaler market is segmented on the basis of device type, application, and end-user. On the basis of device, the market is sub-segmented into metered dosed inhaler and dry powdered inhaler. The dry powder inhaler is estimated to have the largest market share in the US preventive inhaler market due to providing an easy inhalation solution. Whereas, the market for metered dose inhaler is estimated to be the fastest-growing at a CAGR during the forecast period owing to innovations and collaborations by the companies for the development of metered dosed inhaler. Based on the application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed. 

(Get 15% Discount on Buying this Report)

A full Report of US Preventive Inhaler Market is Available @  https://www.omrglobal.com/industry-reports/us-preventive-inhaler-market

US Preventive Inhaler Market Segmentation

By Device Type

·        Metered Dose Inhaler

·        Dry Powder Inhaler

By Application

·        Asthma 

·        Chronic Obstructive Pulmonary Disease (COPD)

By End-User

·        Homecare

·        Hospitals and Clinics

Company Profiles

·        3M Co.

·        Acorda Therapeutics, Inc.

·        Adamis Pharmaceuticals Corp.

·        Adherium Ltd.

·        Aradigm Corp.

·        AstraZeneca PLC

·        Boehringer Ingelheim International GmbH 

·        Drive Devilbiss Healthcare LLC

·        GlaxoSmithKline PLC

·        Koninklijke Philips N.V.

·        Manta Devices LLC

·        Novartis AG

·        Omron Healthcare Inc.

·        ResMed Corp.

·        Pulmatrix Inc.

·        Savara, Inc.

·        Sunovion Pharmaceuticals

·        Teva Pharmaceuticals Industries Ltd.

Reasons to buy from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404